SCE-Medical-Oncology

MRCPUK SCE-Medical-Oncology - Study Material - Medical Oncology (Specialty Certificate Examination)

MRCP(UK) SCE-Medical-Oncology practice questions on Medical Oncology (Specialty Certificate Examination) — covering Breast cancer, Colorectal and anal cancer, Lung and thoracic cancer, Carcinoma of unknown origin, Ovarian cancer, and more — with answers and explanations for every question.

· Updated November 16, 2026
80 practice questions Instant feedback Ask AI on every question 🆓 Free — no signup
Study4Pass Exam Product
FREE — NO SIGNUP

Start the free SCE-Medical-Oncology practice test

  • Real exam-style questions
  • Instant answers & explanations
  • Ask AI on every question
  • See your readiness score
Free forever · No payment details asked

The 1st SCE-Medical-Oncology AI-Enabled Practice Test

  • Ask AI under every question
  • Works with your ChatGPT, Gemini, Claude or Copilot
  • Concept explanations, not just answers
  • Free to start

SCE-Medical-Oncology Study4Pass Exam Detail

Get ready to conquer the MRCPUK SCE-Medical-Oncology – Medical Oncology (Specialty Certificate Examination) certification with Study4Pass. Our platform combines realistic exam simulations, up-to-date content, and an intuitive interface to guide you every step of the way and boost your confidence on exam day.

Question & Answers

80

Free Updates

90 Days
Free 90 days update

Latest updated date

November 16, 2026

What is in the SCE-Medical-Oncology Premium File?

Medical Oncology (Specialty Certificate Examination) FAQ's

What is the Medical Oncology SCE exam?

The Specialty Certificate Examination in Medical Oncology is a Specialty Certificate Examination (SCE) in the MRCP(UK) programme of the Federation of the Royal Colleges of Physicians of the UK, taken by doctors in Medical Oncology specialty training. It is a standalone specialty certificate, separate from the MRCP(UK) Diploma (Part 1, Part 2 Written and PACES). This Study4Pass bank is independent practice material; it is not the official examination.

What is the format of the Medical Oncology SCE exam?

Per the Federation's SCE/ESE Regulations (April 2026), every SCE consists of two papers, each 3 hours long with 100 best-of-five multiple-choice questions — 200 questions in total — delivered as computer-based testing at a test centre. There is one mark per correct answer, no negative marking, and a maximum of six attempts.

What is the passing score for the Medical Oncology SCE exam?

SCE pass standards are equated per specialty by the Federation and there is no fixed percentage pass mark. The Federation's owner metrics captured in the verification file give the Medical Oncology 2025 pass score as 371 (equated; 61.9%). The MRCP(UK) Diploma pass marks (Part 1: 450, Part 2 Written: 444) apply to the diploma examinations only and do not apply to this SCE.

What does the Medical Oncology SCE exam cover?

The verbatim owner blueprint covers 27 areas (question counts out of 200 across both papers): Breast cancer 14; Colorectal and anal cancer 14; Lung and thoracic cancer 14; Carcinoma of unknown origin 7; Ovarian cancer 7; Germ cell tumours 7; Oesophagogastric cancer 6; Lymphoma 3; Uterine cancer 3; Hepatobiliary cancer 5; Skin cancer 5; Sarcoma 5; Leukaemia 1; Prostate cancer 3; Urothelial cancer 3; Cervical cancer 3; Head and neck cancer 2; CNS cancer 2; Renal cell cancer 3; Endocrine cancer 2; Scientific basis of malignancy 18; Professional skills 14; Acute oncology 20; Clinical research, ethics and economics 8; Systemic anticancer therapy 18; Supportive therapies and palliative care 10; Standard operating procedures 3. The blueprint notes that the counts are an indication of the likely number of questions and the actual number may vary slightly.

Who should take the Medical Oncology SCE exam?

Doctors in medical oncology specialty training, and physicians who deliver systemic anticancer therapy, who are preparing for the MRCP(UK) Specialty Certificate Examination in Medical Oncology.

How many questions are in this Medical Oncology SCE practice bank, and how is it weighted?

This Study4Pass bank has 80 original practice questions (68 single-best-answer style and 12 two-correct-answer questions), allocated across the blueprint areas in proportion to the owner blueprint counts where the blueprint publishes them. The real examination has 200 questions, so the bank is a practice set, not a replica of the full paper.

Hot Exams Monthly
& Weekly

Study4Pass Exam Product
Cisco | 200-301

Cisco Certified Network Associate

1113 Practice Exam Questions & Answers
Study4Pass Exam Product
Isaca | COBIT-2019

COBIT 2019 Foundation

187 Practice Exam Questions & Answers
Study4Pass Exam Product
Microsoft | AZ-900

Microsoft Azure Fundamentals

582 Practice Exam Questions & Answers
Study4Pass Exam Product
Microsoft | PL-300

Microsoft Power BI Data Analyst

295 Practice Exam Questions & Answers
Study4Pass Exam Product
Cisco | 350-701

Implementing and Operating Cisco Security Core Technologies (SCOR 350-701)

687 Practice Exam Questions & Answers
Study4Pass Exam Product
Microsoft | AZ-104

Microsoft Azure Administrator

813 Practice Exam Questions & Answers
Study4Pass Exam Product
Linux Foundation | CKS

Certified Kubernetes Security Specialist (CKS)

77 Practice Exam Questions & Answers
Study4Pass Exam Product
PMI | PMP

Project Management Professional

570 Practice Exam Questions & Answers
Study4Pass Exam Product
HashiCorp | Terraform-Associate

HashiCorp Certified: Terraform Associate

101 Practice Exam Questions & Answers
Study4Pass Exam Product
Microsoft | MB-230

Microsoft Dynamics 365 for Customer Service

283 Practice Exam Questions & Answers
Study4Pass Exam Product
PEOPLECERT | DevOps-SRE

PeopleCert DevOps Site Reliability Engineer (SRE)

91 Practice Exam Questions & Answers
Study4Pass Exam Product
Microsoft | MD-102

Endpoint Administrator

179 Practice Exam Questions & Answers
Study4Pass Exam Product
Microsoft | SC-200

Microsoft Security Operations Analyst

243 Practice Exam Questions & Answers
Study4Pass Exam Product
Isaca | CISM

Certified Information Security Manager

258 Practice Exam Questions & Answers
Study4Pass Exam Product
IIBA | CBAP

Certified Business Analysis Professional (CBAP)

498 Practice Exam Questions & Answers
Study4Pass Exam Product
Microsoft | MS-721

Collaboration Communications Systems Engineer

156 Practice Exam Questions & Answers
Study4Pass Exam Product
ECCouncil | 212-82

Certified Cybersecurity Technician (CCT)

60 Practice Exam Questions & Answers
Study4Pass Exam Product
Nokia | 4A0-114

Nokia Border Gateway Protocol Fundamentals for Services

85 Practice Exam Questions & Answers
Study4Pass Exam Product
Okta | Okta-Certified-Professional

Okta Certified Professional Exam

118 Practice Exam Questions & Answers

SCE-Medical-Oncology Medical Oncology (Specialty Certificate Examination) — Exam Overview

Quick Facts

SCE-Medical-Oncology — Specialty Certificate Examination in Medical Oncology — is one of the 11 Specialty Certificate Examinations in the MRCP(UK) programme run by the Federation of the Royal Colleges of Physicians of the UK. Like every SCE it is examined with two 3-hour papers of 100 best-of-five questions (200 questions in total), delivered as in-centre computer-based testing, with one mark per correct answer, no negative marking and a maximum of six attempts; pass standards are equated per specialty and there is no fixed percentage pass mark. Its verbatim owner blueprint distributes the 200 questions across 27 areas: Breast cancer 14; Colorectal and anal cancer 14; Lung and thoracic cancer 14; Carcinoma of unknown origin 7; Ovarian cancer 7; Germ cell tumours 7; Oesophagogastric cancer 6; Lymphoma 3; Uterine cancer 3; Hepatobiliary cancer 5; Skin cancer 5; Sarcoma 5; Leukaemia 1; Prostate cancer 3; Urothelial cancer 3; Cervical cancer 3; Head and neck cancer 2; CNS cancer 2; Renal cell cancer 3; Endocrine cancer 2; Scientific basis of malignancy 18; Professional skills 14; Acute oncology 20; Clinical research, ethics and economics 8; Systemic anticancer therapy 18; Supportive therapies and palliative care 10; Standard operating procedures 3. This Study4Pass practice bank contains 80 original practice questions aligned to that blueprint. Quota note: Leukaemia carries an owner count of 1/200, which under the bank rule (owner count x 0.4, largest-remainder rounding to exactly 80) rounds to 0 questions; the topic is retained in the domain list with its verbatim owner weight.

Who this exam is for

Doctors in medical oncology specialty training, and physicians who deliver systemic anticancer therapy, who are preparing for the MRCP(UK) Specialty Certificate Examination in Medical Oncology.

Exam Domains

Breast cancer — 14/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering early breast cancer adjuvant therapy; HER2-positive disease; endocrine therapy; metastatic treatment sequencing.

Colorectal and anal cancer — 14/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering adjuvant chemotherapy; RAS and BRAF testing; metastatic sequencing; anal cancer chemoradiation.

Lung and thoracic cancer — 14/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering eGFR, ALK and PD-L1 testing; small cell lung cancer; mesothelioma; immunotherapy.

Carcinoma of unknown origin — 7/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering favourable and unfavourable subsets; immunohistochemistry; molecular profiling.

Ovarian cancer — 7/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering first-line chemotherapy; PARP inhibitors and BRCA; platinum sensitivity.

Germ cell tumours — 7/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering risk stratification; BEP chemotherapy; tumour markers AFP, hCG and LDH; surveillance.

Oesophagogastric cancer — 6/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering perioperative chemotherapy; HER2 testing; metastatic treatment.

Lymphoma — 3/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering hodgkin lymphoma; diffuse large B-cell lymphoma; ABVD and R-CHOP.

Uterine cancer — 3/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering endometrial cancer staging and adjuvant therapy; mismatch repair testing.

Hepatobiliary cancer — 5/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering hepatocellular carcinoma; cholangiocarcinoma; pancreaticobiliary supportive care.

Skin cancer — 5/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering melanoma adjuvant therapy; BRAF/MEK inhibition; basal cell carcinoma.

Sarcoma — 5/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering soft tissue sarcoma chemotherapy; GIST and imatinib; bone sarcomas.

Leukaemia — 1/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering acute leukaemia presentation and referral; tumour lysis risk.

Prostate cancer — 3/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering androgen deprivation; androgen receptor pathway inhibitors; metastatic hormone-sensitive disease.

Urothelial cancer — 3/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering cisplatin eligibility; perioperative chemotherapy; immunotherapy.

Cervical cancer — 3/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering chemoradiation; HPV and screening; recurrent disease.

Head and neck cancer — 2/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering hPV-positive oropharyngeal cancer; chemoradiation; EGFR inhibition.

CNS cancer — 2/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering glioblastoma chemoradiation; primary CNS lymphoma; brain metastases.

Renal cell cancer — 3/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering risk stratification; VEGF and immunotherapy combinations.

Endocrine cancer — 2/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering thyroid cancer; adrenocortical carcinoma; neuroendocrine tumours.

Scientific basis of malignancy — 18/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering hallmarks of cancer; oncogenes and tumour suppressors; DNA repair; angiogenesis; immune evasion; carcinogenesis.

Professional skills — 14/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering breaking bad news; consent for chemotherapy; multidisciplinary team working; communication with patients and families.

Acute oncology — 20/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering neutropenic sepsis; tumour lysis syndrome; spinal cord compression; hypercalcaemia; superior vena cava obstruction; immunotherapy toxicities.

Clinical research, ethics and economics — 8/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering trial phases; endpoints; consent and ethics; health economics and QALYs.

Systemic anticancer therapy — 18/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering cytotoxic mechanisms and toxicities; targeted therapy; immunotherapy; endocrine therapy; dose calculation and organ dysfunction.

Supportive therapies and palliative care — 10/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering antiemetics; pain control; malignant effusions; bone-modifying agents; end-of-life care.

Standard operating procedures — 3/200

One of the 27 areas in the verbatim owner blueprint for the Medical Oncology (Specialty Certificate Examination) (Federation of the Royal Colleges of Physicians of the UK blueprint PDF), covering chemotherapy prescribing and checking; extravasation; governance and incident reporting.

Preparing for SCE-Medical-Oncology

Work through the practice questions in study mode first, read every explanation, then switch to timed practice. Weight your revision by the domain weightings above and revisit the topics you score lowest on until your practice scores are consistent.

Other Useful Related Exams by MRCPUK

Explore Other Vendors' Certified Exams

Write Your Review on SCE-Medical-Oncology Medical Oncology (Specialty Certificate Examination)

SCE-Medical-Oncology Customer Reviews

No reviews yet

Be the first to share your experience with this exam.